The reduction of blindness in children is one of the major goals of the World Health Organization’s Vision 2020 program.
1 As the leading cause of childhood blindness, retinopathy of prematurity (ROP) is estimated to affect more than 184 700 children worldwide.
2 The incidence and severity of ROP are associated with various factors, such as birth weight (BW), gestational age (GA), oxygen exposure, blood transfusions, and several systemic risk factors.
3-10 Early screening can effectively reduce childhood blindness and health care costs associated with ROP.
11-15 Because of the lack of widespread implementation of a cost-effective screening strategy, the cost of ROP screening to the global health system remains high.
12,14 While the window for treating ROP is brief, treatment has multigenerationally beneficial consequences for individuals, families, societies, and national economies.
11,13,14 Thus, early screening, regular monitoring, and timely treatment are critical for premature infants.